Dimensional Fund Advisors’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
Other funds holding KYMR
BBA
ACA
BI
SL
Dimensional Fund Advisors's KYMR Position: Q2 2026 in Review
Dimensional Fund Advisors increased its Kymera Therapeutics (KYMR) stake by 26% in Q2 2026, buying an estimated $13.1M and bringing the position to 745,152 shares worth $85.4M. The position accounts for 0.02% of the portfolio, ranked #1298.
Dimensional Fund Advisors first reported a position in KYMR in Q4 2021 and has held it in 18 quarters since. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.
- Dimensional Fund Advisors held 745,152 shares of Kymera Therapeutics worth $85.4M as of Q2 2026.
- Dimensional Fund Advisors bought 152,273 Kymera Therapeutics shares in Q2 2026, an estimated $13.1M.
- Kymera Therapeutics made up 0.02% of Dimensional Fund Advisors's portfolio in Q2 2026, its #1298 holding.
- Dimensional Fund Advisors first reported a position in Kymera Therapeutics in Q4 2021 and has held it in 18 quarters since.
- 276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.